BOLDPATH LIFE STRATEGIES – Trademark Portfolio
Entity Type: 99
BOLDPATH LIFE STRATEGIES holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BOLDIDEA. The owner is based in St. Paul, MN.
Suite 46
3432 Denmark Ave
St. Paul, MN 55123
Showing of trademarks Trademarks
Trademark Classifications
BOLDPATH LIFE STRATEGIES's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does BOLDPATH LIFE STRATEGIES have?
BOLDPATH LIFE STRATEGIES has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does BOLDPATH LIFE STRATEGIES file in?
BOLDPATH LIFE STRATEGIES files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are BOLDPATH LIFE STRATEGIES's most well-known trademarks?
BOLDPATH LIFE STRATEGIES's registered trademark portfolio includes well-known marks such as BOLDIDEA. These are among 1 currently registered trademark in the portfolio.
What is BOLDPATH LIFE STRATEGIES's trademark registration success rate?
BOLDPATH LIFE STRATEGIES has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.